Recent Updates
Recently added Catalysts
TWST Positive Sentiment

Twist Bioscience to Present at Upcoming Investor Conferences

Monday, November 9, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Twist Bioscience CEO Emily M. Leproust and CFO Adam Laponis will present at the Jefferies Global Healthcare Conference in London on November 17. They will also participate in the Evercore H.C. Weisbaum Healthcare Conference. These engagements aim to update investors on company progress and strategic direction.

Market Sentiment Analysis

POSITIVE FACTORS

  • Twist Bioscience is actively engaging with investors.
  • Participation in notable conferences enhances visibility.
  • Leadership presence at events reflects company confidence.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value healthcare company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate in fireside chats at the following upcoming investor conferences. Jefferies Global Healthcare Conference in London, UK on Tuesday, November 17; fireside chat at 3:00 pm Greenwich Mean Time 9th Annual Evercore Healt

Frequently Asked Questions

Who will represent Twist Bioscience at the conferences?

Emily M. Leproust and Adam Laponis will represent the company.

When is the Jefferies Global Healthcare Conference?

The conference is scheduled for November 17.

What type of events will Twist Bioscience participate in?

They will participate in fireside chats at investor conferences.

Where will the Jefferies Global Healthcare Conference be held?

It will be held in London, UK.

ShareAdd on Google
Tags: TWST Twist Bioscience investor conferences Emily Leproust Adam Laponis Jefferies Global Healthcare Conference
Last updated: Nov 9, 2026

Biotech snapshot

Cash runway
$167M liquidity · $0M/mo burn
Low dilution risk